Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins
July 17, 2024 07:00 ET
|
Draupnir Bio
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies
July 17, 2024 05:15 ET
|
BioProcess360
BioProcess360 Partners announce the launch of a new investment fund to support businesses with the growth of emerging bioprocessing technologies
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
July 16, 2024 09:00 ET
|
Flag Therapeutics, Inc.
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
July 16, 2024 09:00 ET
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals appoints Tamara Dillon as Chief Human Resources Officer
Seyltx Announces Positive Pre-Clinical Dose-Ranging Data with Its Selective Oral Small-Molecule Inhibitor of GluN2B Illustrating Near-Complete Suppression of Refractory Chronic Cough within the Therapeutic Index
July 16, 2024 07:30 ET
|
Seyltx, Inc.
- Results will be presented at the London International Cough Symposium on July 18, 2024 - Dose dependent cough suppression to >90% in vivo with no effect on basal respiratory rates - Multiple...
Abivax Provides Operational and Key Program Update
July 15, 2024 16:00 ET
|
Abivax
Abivax Provides Operational and Key Program Update Phase 3 ABTECT Trial evaluating obefazimod in moderately to severely active ulcerative colitis (UC) on track to complete enrollment in early Q1...
Panthera BioSolutions Launches Pharmaceutical Good Manufacturing Practice (GMP) Foundational Training Course with Dallas College to Advance Workforce Talent Pipeline in North Texas
July 15, 2024 11:57 ET
|
BHIANT
DALLAS, July 15, 2024 (GLOBE NEWSWIRE) -- The Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) is proud to announce a strategic partnership between Dallas College and Panthera...
Kraig Biocraft Laboratories Completes Phase One of its Spider Silk Production Facility Expansion
July 15, 2024 07:05 ET
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) completed the first phase of construction for its production facility expansion to support the Company's third production wave
Tevogen Bio Issues Letter to Stockholders Highlighting Recent Achievements, Growth Plans, and Consideration of a Potential Share Buyback
July 11, 2024 12:21 ET
|
Tevogen Bio Inc
WARREN, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing...
Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
July 11, 2024 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed a worldwide license agreement with...